Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
October 12, 2026
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
8 min read
False
Advertisement
Biopharma
Musings from The Power List: Andres Sirulnik
By Andres Sirulnik
October 5, 2026
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
4 min read
Musings from The Power List: Renee Aguiar-Lucander
September 28, 2026
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
2 min read
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
5 min read
China’s Biopharma Homecoming
By James Strachan, Henry Thomas
September 1, 2026
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
7 min read
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
By David Butler
August 31, 2026
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products
4 min read
The Hidden Complexity of Stability Storage
By Lori A. Ball
August 27, 2026
Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong
9 min read
Green Shoots, Gray Skies
By Olivia Anderson, James Strachan
August 26, 2026
Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”
9 min read
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
7 min read
The Mindset for Success in Biopharma's New Multipolar World
By Jessica Allerton, James Strachan
August 18, 2026
From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market
10 min read
